Strides Pharma Inc.Potassium Chloride Extended-Release Tablets
Failed Dissolution Specifications
11,818 recalls · Class II, newest first
Failed Dissolution Specifications
CGMP Deviations
CGMP Deviations
GMP Deviations: Potential to contain 1-propanol.
GMP Deviations: Potential to contain 1-propanol.
cGMP Deviations
cGMP Deviations
Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.
CGMP Deviations: All other lots are being recalled because they were manufactured under the same conditions as the product lots found to contain methanol.
Failed Impurity /Degradation Specifications
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg
Labeling Not Elsewhere Classified: Product labeled to contain methanol
Labeling Not Elsewhere Classified: Product labeled to contain methanol
Subpotent drug
Failed Tablet/Capsule Specification; complaint of bulging tablet
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility